<DOC>
	<DOCNO>NCT02689375</DOCNO>
	<brief_summary>25 participant back pain previous spinal surgery enrol single NHS site England . Participants already discuss spinal cord stimulation ( SCS ) pain management consultant invite participate . Participants attend 10 visit period 66 month . At visit one , study suitability screen informed consent conduct . Suitable participant book SCS trial lead implant external programmable High Frequency battery trial box day case ( Visit 2 ) . Participants contact next 21 day assess trial progress book follow appointment clinic remove trial lead ( Visit 3 ) treatment decision make . If participant determine successful trial list implanted full HF10 SCS implant ( Visit 4 ) . The participant proceed full HF10 SCS implant review Clinic 6 , 12 , 24 , 36 , 48 60 month post procedure . Their participation study longer 66 month . A successful trial define reduction pain 30 % Visual Analogue Scale . Participants obtain 30 % reduction 21 day class failed trial lead remove review clinic investigator alternative treatment plan ( Visit 4 ) . If participant determine failed trial HF10 , remain study consent full follow schedule . The follow-up failed trial cohort conduct via telephone reduce burden trial group .</brief_summary>
	<brief_title>A Prospective , Open Label , Pilot Study Patient OutcoMes Following Successful TriAl High Frequency SpInal CorD Stimulation 10kHz ( HF10™ ) Leading Permanent Implant Compared Trial Failure Standard CarE TreatmeNt Persistent Low BACK Pain Neuropathic Origin</brief_title>
	<detailed_description />
	<mesh_term>Back Pain</mesh_term>
	<mesh_term>Low Back Pain</mesh_term>
	<criteria>I . Patient 18 year age old give write informed consent . II . Has persistent chronic predominant low back pain neuropathic origin , radiculopathy , minimum 6 month III . Visual Analogue Scale ( VAS ) back pain score least 50 mm baseline IV . Confirmation pain neuropathic origin SLANSS score ( ≥12 ) AND PainDETECT score ( ≥19 ) V. Total daily dose opioids equivalent ≤200mg Morphine VI . No previous open spinal surgery ( percutaneous procedure nucleoplasty consider open surgical procedure ) VII . Failed conservative therapy physiotherapy , chiropractor , hydrotherapy , TENS . VIII . MRI within previous 18 month ( per standard care ) IX . In investigator opinion patient suitable candidate HF10 I . Patient mechanical spine instability base flexion/extension test lumbar spine ( document last 6 month ) II . Patient pregnant , pregnancy suspect plan within first six month study timeframe . III . Patient cardiac pacemaker , automatic defibrillator , implanted device , make trial impossible . IV . Allergy device component drug use intend procedure . V. Medical comorbidities preclude surgical intervention . VI . Patient incapable understand respond study questionnaire VII . Patient incapable understand operate patient programmer handset . VIII . History previous open spinal surgery ( percutaneous procedure ) IX . Patient morbidly obese ( BMI ≥ 40 ) . X . Patient simultaneously participate another device drug study within last 30 day . XI . Patient spinal fracture , tumour infection . XII . Clinical evidence cauda equina syndrome . XIII . Progressive neurologic deficit .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>100 Years</maximum_age>
	<verification_date>February 2016</verification_date>
</DOC>